Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Swapnil S Desale

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Therapeutic Delivery|November 25, 2015
Polymer-based vehicles for therapeutic peptide deliveryJinjin Zhang, Swapnil S Desale, Tatiana K Bronich
AAPS Pharmscitech|July 28, 2010
Synthesis of MCC-PEG conjugate and its evaluation as a superdisintegrantMangesh R Bhalekar, Swapnil S Desale, Ashwini R Madgulkar
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 17, 2015
Nanogels: An overview of properties, biomedical applications and obstacles to clinical translationKruti S Soni, Swapnil S Desale, Tatiana K Bronich
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 19, 2015
Targeted delivery of platinum-taxane combination therapy in ovarian cancerSwapnil S Desale, Kruti S Soni, Svetlana Romanova, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 14, 2013
Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancerSwapnil S Desale, Samuel M Cohen, Yi Zhao, et al.
Oncotarget|February 10, 2016
Marked enhancement of lysosomal targeting and efficacy of ErbB2-targeted drug delivery by HSP90 inhibitionSrikumar M Raja, Swapnil S Desale, Bhopal Mohapatra, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 10, 2015
Polypeptide-based nanogels co-encapsulating a synergistic combination of doxorubicin with 17-AAG show potent anti-tumor activity in ErbB2-driven breast cancer modelsSwapnil S Desale, Srikumar M Raja, Jong Oh Kim, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Therapeutic Delivery|November 25, 2015
Polymer-based vehicles for therapeutic peptide deliveryJinjin Zhang, Swapnil S Desale, Tatiana K Bronich
AAPS Pharmscitech|July 28, 2010
Synthesis of MCC-PEG conjugate and its evaluation as a superdisintegrantMangesh R Bhalekar, Swapnil S Desale, Ashwini R Madgulkar
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 17, 2015
Nanogels: An overview of properties, biomedical applications and obstacles to clinical translationKruti S Soni, Swapnil S Desale, Tatiana K Bronich
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 19, 2015
Targeted delivery of platinum-taxane combination therapy in ovarian cancerSwapnil S Desale, Kruti S Soni, Svetlana Romanova, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 14, 2013
Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancerSwapnil S Desale, Samuel M Cohen, Yi Zhao, et al.
Oncotarget|February 10, 2016
Marked enhancement of lysosomal targeting and efficacy of ErbB2-targeted drug delivery by HSP90 inhibitionSrikumar M Raja, Swapnil S Desale, Bhopal Mohapatra, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 10, 2015
Polypeptide-based nanogels co-encapsulating a synergistic combination of doxorubicin with 17-AAG show potent anti-tumor activity in ErbB2-driven breast cancer modelsSwapnil S Desale, Srikumar M Raja, Jong Oh Kim, et al.
Pageof 1